Search - tctmd.com

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization with Drug-Eluting Stent in Patients with Acute Myocardial Infarction

Presenter: Shin Eun Lee, Myung Ho Jeong, Young Jo Kim, Dong Yub Lee, Seong Jung Park

January 31, 2013

Presentation TCT 2013

Impact of Smoking on Outcomes of Acute Myocardial Infarction After Drug-Eluting Stent Implantation: The Smoker’s Paradox

Presenter: Yun-Kyeong Cho, Ji-Hyun Sohn, Hyun-Ok Cho, Hyoung-Seob Park, Hyuck-Jun Yoon, Hyungseop Kim, Chang-Wook Nam, Seung-Ho Hur, Yoon-Nyun Kim, Kwon-Bae Kim

January 31, 2013

Advertisement

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

心脏传导阻滞本身并不能使AMI后的预后恶化

Heart Block Itself Does Not Worsen Prognosis After AMI

El Bloqueo Cardíaco Per Se no Empeora el Pronóstico Post-IAM

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes(2)

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

Long-term Outcome After Drug-Eluting vs. Bare-Metal Stent Implantation in Patients with STEMI

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization with Drug-Eluting Stent in Patients with Acute Myocardial Infarction

Impact of Smoking on Outcomes of Acute Myocardial Infarction After Drug-Eluting Stent Implantation: The Smoker’s Paradox

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content